Recent studies have found that silencing or pharmacological inhibition of NEU1 prevented cardiac remodeling in response to pressure overload, inhibited cardiomyocytes hypertrophy and attenuated ischemia-related cardiac injury 10, 31. This evidence concerns the gene NEU1 and ischemia.